Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01278823 · ClinicalTrials.gov registry record · NA
Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01278823 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 18 participants.
The verdict
NCT01278823, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of bariatric surgery on blood sugar control and underlying mechanisms that contribute to type 2 diabetes in men and women with a BMI between 27 and 42. Sixty subjects will be randomized to either undergo the roux-en-y gastric bypass operation or intensive medical, dietary and exercise management.
Interventions
- PROCEDURE laparoscopic roux en y gastric bypass operation
- OTHER medical management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-01 |
| Est. Completion | 2017-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01278823
The ClinicalTrials.gov registry entry for NCT01278823 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which laparoscopic roux en y gastric bypass operation is the first listed.
NCT01278823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01278823 about?
NCT01278823 is a clinical study titled "Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes". The purpose of this study is to determine the effects of bariatric surgery on blood sugar control and underlying mechanisms that contribute to type 2 diabetes in men and women with a BMI between 27 and 42. Sixty subjects will be randomized to either undergo the roux-en-y gastric bypass operation or ...
What is the current status of trial NCT01278823?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2011-01. Estimated completion is 2017-02-15.
What interventions are being tested in trial NCT01278823?
The interventions under investigation include: laparoscopic roux en y gastric bypass operation (PROCEDURE), medical management (OTHER).
Who is sponsoring clinical trial NCT01278823?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.